Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Iart Luca Shytaj

Lecturer

University of Bristol

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

50%

Virology

70%

Hiv

60%

Antiviral Therapy

40%

Inflammatory Biology

30%

Immune Response

20%

Macrophage Biology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening

Article Link

Year:

2025

Aquarius helicase facilitates HIV-1 integration into R-loop enriched genomic regions

Article Link

Year:

2025

Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV

Article Link

Year:

2025

Fast pH‐Driven Solubilization Method of Realgar (As 4 S 4 ) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes

Article Link

Year:

2025

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro

Article Link

Year:

2024

A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo

Article Link

Year:

2023

Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.

Article Link

Year:

2023

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir to Inhibit SARS-CoV-2 Replication in Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

Article Link

Year:

2022

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment

Article Link

Year:

2022

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment

Article Link

Year:

2022

Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress

Article Link

Year:

2021

Patient-derived HIV-1 Nef alleles reveal uncoupling of CD4 downregulation and SERINC5 antagonism functions of the viral pathogenesis factor.

Article Link

Year:

2020

Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor

Article Link

Year:

2020

Alterations of redox and iron metabolism accompany the development of HIV latency

Article Link

Year:

2020

NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice

Article Link

Year:

2020

Collaborators11

Xinlai Cheng

GERMANY

Sergi Padilla-Parra

King’s College London

UNITED KINGDOM

Jane McKeating

Professor

University of Oxford

UNITED KINGDOM

Vibor Laketa

Head of Infectious Diseases Imaging Platform (IDIP)

Ruprecht Karls Universität Heidelberg

GERMANY

Julia Maria Adler

Charité - Universitätsmedizin Berlin

GERMANY

Oliver T Fackler

GERMANY

Liv Zimmermann

Heidelberg University

GERMANY

Inês de Castro

Lecturer

Brunel University London

UNITED KINGDOM

Lishomwa Ndhlovu

Professor

Weill Cornell Medical College

UNITED STATES

Mirko Cortese

Associate Professor

Università degli studi della Campania Luigi Vanvitelli Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farm

ITALY

Petr Chlanda

GERMANY

How do I reach out?

Meet Kite AI